KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

GoodRx Holdings (GDRX) Non Operating Income (2019 - 2025)

GoodRx Holdings (GDRX) has disclosed Non Operating Income for 7 consecutive years, with -$8.5 million as the latest value for Q4 2025.

  • Quarterly Non Operating Income fell 280.64% to -$8.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$14.5 million through Dec 2025, down 187.4% year-over-year, with the annual reading at -$31.0 million for FY2025, 1063.68% down from the prior year.
  • Non Operating Income hit -$8.5 million in Q4 2025 for GoodRx Holdings, down from $694000.0 in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $18.5 million in Q4 2022 to a low of -$8.5 million in Q4 2025.
  • Historically, Non Operating Income has averaged -$2.2 million across 5 years, with a median of -$5.9 million in 2021.
  • Biggest YoY gain for Non Operating Income was 163.77% in 2021; the steepest drop was 36931.25% in 2021.
  • Year by year, Non Operating Income stood at $17.7 million in 2021, then rose by 4.46% to $18.5 million in 2022, then tumbled by 144.74% to -$8.3 million in 2023, then skyrocketed by 156.83% to $4.7 million in 2024, then tumbled by 280.64% to -$8.5 million in 2025.
  • Business Quant data shows Non Operating Income for GDRX at -$8.5 million in Q4 2025, $694000.0 in Q2 2025, and -$6.7 million in Q1 2025.